Home D-Pharm

D-Pharm

In operation
Post-IPO Round
Innovative Drug Developer

Basic Information

D-Pharm (TASE: DPRM) is a drug development company focused on innovative drugs for the treatment of central nervous system (CNS) disorders. The company has a particular interest in developing innovative drugs for degenerative and age-related diseases.
D-Pharm Ltd.
Israel
15~50 people
January 01, 1993
thorovitz@dpharm.com